Our data demonstrated that compared with obese patients, FGF21 levels were positively correlated with obesity-related AN and markers of insulin resistance (fasting insulin, HOMA-IR). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.